Pages Menu
TwitterRssFacebook
ISSN (Online): 0975-8232,
ISSN (Print): 2320-5148

International Journal Of
Pharmaceutical Sciences And Research

Inclusion in Web of Science (Thomson Reuters) - ESCI
Projected Impact Factor (2018): 0.83 , CiteScore (2017): 0.27
Five-Year Projected Impact Factor: 1.81

Categories Menu

Most Cited

CITATIONS REPORT: (Source- Google Scholar)
Year201020112012201320142015201620172018Total
No. of Published Articles2404807606337026556226617025455
Citations2027347040842232160210436783925115579
Article published in 2010 and 2011: 720, Citation in 2012 to articles Published in 2010 and 2011- 5497
Impact Factor (2012): 5497/720 = 7.63 (On the basis of citations)

Article published in 2011 and 2012: 1240, Citation in 2013 to articles Published in 2011 and 2012- 7554
Impact Factor (2013): 7554/1240 = 6.09 (On the basis of citations)

Article published in 2012 and 2013: 1393, Citation in 2014 to articles Published in 2012 and 2013- 6316
Impact Factor (2014): 6316/1393 = 4.53 (On the basis of citations)

Article published in 2013 and 2014: 1335, Citation in 2015 to articles Published in 2013 and 2014- 3834
Impact Factor (2015): 3834/1335 = 2.87 (On the basis of citations)

Article published in 2014 and 2015: 1357, Citation in 2016 to articles Published in 2014 and 2015- 2645
Impact Factor (2016): 2645/1357 = 1.94 (On the basis of citations)

Article published in 2015 and 2016: 1277, Citation in 2017 to articles Published in 2015 and 2016- 1721
Impact Factor (2017): 1721/1277 = 1.34 (On the basis of citations)

Article published in 2016 and 2017: 1283, Citation in 2018 to articles Published in 2016 and 2017- 1070
Impact Factor (2018): 1070/1283 = 0.83 (On the basis of citations)


Five Year Projected Impact Factor: 5947/3273 = 1.81
Total Citations: 15579
 
Title
Views
PDF
Cited
17.

MODULATORY ROLE OF WITHENIA SOMNIFERA ROOT EXTRACT MIXED PELLETED FEED ON PESTICIDE INDUCED HEPATIC ANOMALIES’ IN FRESH WATER CATFISH CLARIAS BATRACHUS (LINN.)

The pharmacological activity of Withenia somnifera commonly called Ashwagandha, a herb having multi-medicinal properties, was investigated   against carbofuran exposed hepatic anomalies in the air breathing fish Clarias batrachus. Fishes were exposed to 1 mg/L carbofuran for three weeks to induce the toxic effects. These fishes were then fed with Withenia somnifera root extract mixed pelleted fe...

Prakriti Verma and A. Nath*

Cell Biology & Toxicology Laboratory Department of Zoology, Patna University, Patna, Bihar, India

DOI: 10.13040/IJPSR.0975-8232.6(10).4243-51

4243-51

1597

404

47.

T3 IS AS GOOD A POINTER OF CREATINE KINASE LEVELS IN EUTHYROIDS AS T4 IS IN HYPOTHYROIDS

Aim: Hypothyroidism is one of the commonest metabolic diseases which afflicts females more than males and is often associated with myopathy. Reports on relationship of muscle-markers with thyroid hormones in the (a) euthyroid population in general and (b) hypothyroid population in India are scarce. Materials and Methods: A randomized case-control study on the female population for which 60 hypothy...

S. Jyothi, S. Baliarsingh *, K. Pratibha, V. Vijayakumari, K. Nanda and M. Tejomani

Department of Biochemistry, ESIC Medical College and PGIMSR, Rajajinagar, Bangalore, Karnataka, India

DOI: 10.13040/IJPSR.0975-8232.6(10).4491-95

4491-95

1786

541

25.

SCREENING OF UNIQUE BINDING SITE SPECIFIC LIGAND FOR CARBONIC ANHYDRASE IX

Cancer is a common and widespread cause of human death in the world. Treatments like chemotherapy and radiotherapy facilitate in prolonging the patient’s life however in some cases cancer can be prevented. Cancers like breast, prostate, colon, renal cell carcinoma are caused by the overexpression of an enzyme termed Carbonic Anhydrase IX (CAIX). In 2015, 60,290 new cases of breast cancer alone a...

Priyanka Padia, Kajal Kumari, Shikha Kumari and Vidya Niranjan*

Department of Biotechnology, R.V. College of Engineering, Mysore Road, Bengaluru, Karnataka, India

DOI: 10.13040/IJPSR.0975-8232.6(11).4772-78

4772-78

1906

632

14.

ANALYTICAL METHOD VALIDATION FOR DETERMINATION OF RELATED SUBSTANCES OF DEXMEDETOMIDINE (IMPURITY-1) IN DEXMEDETOMIDINE HYDROCHLORIDE INJECTION

Dexmedetomidine, approved by the Food and Drug Administration (FDA) in 1999 as a sedative for use in the intensive care unit, is a potent and highly selective α2-adrenoceptor agonist with significant sedative, analgesic and anxiolytic effects mostly used in the intensive care units. This article describes validation for determination of related substances of dexmedetomidine (impurity-1) in dexmed...

Muralee Krishna, Meghana Nadre, Anirudhha Sherikar and Ranjith Reddy *

Glenmark pharmaceutical Limited, Pithampur, Madhya Pradesh, India

DOI: 10.13040/IJPSR.0975-8232.6(12).5070-76

5070-76

3996

1926